Stock listing

Stuttgart:M8W MediWound Ltd. Aktie

German listing (Stuttgart) of MediWound Ltd. · home listing NASDAQ:MDWD

Follow MediWound Ltd. into a list and get an email when it puts out news.

Home listing price · NASDAQ:MDWD

$13.59 USD -0.02 (-0.1%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MDWD

Past year -19.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$13.36 – $13.62 USDNov 20, 2026
Volume
187,835 sharesNov 20, 2026
Market cap
$175.5M USDAt the close on Nov 20, 2026 · price × 12.91M shares outstanding
52-week range
$11.80 – $19.70 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.64M USDMedian day 93,100 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
MediWound Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MDWD · Home$13.59 USD-0.02 (-0.1%)187,835$13.48$13.62$13.36$13.61Close on Nov 20, 2026
Frankfurt:M8W€12.00 EUR-0.20 (-1.6%)—€12.00€12.00€12.00€12.20Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MDWD · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$13.59-0.02-0.1%$13.48$13.62$13.36187,835
$13.61-0.07-0.5%$13.60$14.10$13.60168,461
$13.68+0.13+1.0%$13.50$13.95$13.25156,577
$13.55+0.65+5.0%$12.84$13.59$12.60175,793
$12.90-0.07-0.5%$13.00$13.23$12.77189,678
$12.97-0.85-6.2%$12.60$13.53$12.50354,543
$13.82-0.29-2.1%$14.11$14.11$13.62147,255
$14.11+0.03+0.2%$14.09$14.41$13.97191,851
$14.08-0.17-1.2%$14.24$14.63$13.99268,670
$14.25+0.92+6.9%$13.37$14.29$13.34111,360
$13.33-0.87-6.1%$14.00$14.03$13.30243,052
$14.20+0.81+6.0%$13.05$14.32$12.74329,116
$13.39-0.11-0.8%$13.60$13.81$13.3389,060
$13.50+0.20+1.5%$13.50$13.67$13.11120,421
$13.30-0.56-4.0%$13.94$13.94$13.24110,105
$13.86+0.30+2.2%$13.61$13.97$13.36154,406
$13.56+1.01+8.0%$12.80$13.67$12.61126,554
$12.55+0.485+4.0%$12.10$12.60$12.10117,412
$12.07+0.065+0.5%$11.95$12.13$11.8083,892
$12.00-0.18-1.5%$12.18$12.20$11.8979,300
$12.18+0.08+0.7%$12.02$12.33$12.0288,600
$12.100.000.0%$12.08$12.47$12.01155,300
$12.10-0.60-4.7%$12.58$12.90$12.07233,100
$12.70+0.85+7.2%$11.94$12.76$11.86190,100
$11.85-0.36-2.9%$12.24$12.24$11.8433,400
$12.21+0.30+2.5%$11.99$12.23$11.8793,100
$11.91-0.31-2.5%$12.19$12.34$11.9091,800
$12.22-0.34-2.7%$12.55$12.62$12.1980,400
$12.56+0.02+0.2%$12.50$12.69$12.3565,600
$12.54+0.12+1.0%$12.42$13.15$12.4292,600
$12.42-0.43-3.3%$12.80$13.11$12.42104,400
$12.85-0.30-2.3%$13.13$13.23$12.8172,500
$13.15-0.36-2.7%$13.51$13.53$13.1058,800
$13.51-0.01-0.1%$13.48$13.63$13.3049,900
$13.52-0.08-0.6%$13.68$13.78$13.4348,000
$13.60-0.17-1.2%$13.66$13.77$13.4781,500
$13.77-0.03-0.2%$13.80$13.98$13.5983,900
$13.80-0.13-0.9%$14.04$14.04$13.7430,200
$13.93+0.09+0.7%$13.68$14.00$13.6856,600
$13.84+0.01+0.1%$13.86$14.04$13.7072,600
$13.83+0.18+1.3%$13.77$13.97$13.5061,100
$13.65-0.30-2.2%$13.80$13.80$13.3373,100
$13.95+0.64+4.8%$13.38$13.99$13.3880,700
$13.31-0.09-0.7%$13.49$13.49$13.0072,500
$13.40+0.05+0.4%$13.42$13.49$13.3081,900
$13.35+0.13+1.0%$13.35$13.41$13.1244,300
$13.22-0.25-1.9%$13.58$13.58$13.1279,000
$13.47-0.41-3.0%$13.74$13.74$13.1980,500
$13.88+0.77+5.9%$13.17$14.00$13.17167,900
$13.11-0.60-4.4%$13.81$13.81$12.9578,300
$13.71-0.13-0.9%$13.74$13.82$13.39149,800
$13.84+0.40+3.0%$13.44$14.07$13.21216,000
$13.44+0.15+1.1%$13.20$13.67$13.06195,100
$13.29+0.08+0.6%$13.13$13.41$13.0386,200
$13.21+0.15+1.1%$13.10$13.33$12.8091,200
$13.06+0.44+3.5%$12.71$13.13$12.70104,100
$12.62+0.01+0.1%$12.72$12.99$12.59108,500
$12.61-0.05-0.4%$12.67$12.95$12.55167,000
$12.66-0.58-4.4%$13.18$13.18$12.52165,500
$13.24+0.54+4.3%$12.72$13.25$12.72196,200
$12.70-0.27-2.1%$13.00$13.09$12.61209,600
$12.97-0.03-0.2%$13.07$13.13$12.8580,358
$13.00-0.21-1.6%$13.19$13.27$12.86101,561
$13.21+0.095+0.7%$13.15$13.32$13.0779,800
$13.12-0.475-3.5%$13.60$13.60$13.0681,400

Splits

1 split · NASDAQ:MDWD · every price before a split is adjusted for it

DayRatioWhat
1-for-7Consolidation
Ticker
Stuttgart:M8W
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stuttgart
Currency
EUR

What changed lately

Latest news

All MediWound Ltd. news

MediWound Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
20 in the last 12 months · 170 in all · newest Nov 16, 2026 · oldest 2019
Calls
25 calls with a replay · 25 with a transcript · latest Nov 12, 2026
Decks
17 decks · latest November 2026

Where MediWound Ltd. is listed

ListingExchangeCountryCurrency
NASDAQ:MDWD · Home listingNASDAQUnited StatesUSD
LS Exchange:A110TGLS ExchangeGermanyEUR
Lang & Schwarz:A110TGLang & SchwarzGermanyEUR
BOATS:MDWDBOATSUnited StatesUSD
Frankfurt:M8WFrankfurtGermanyEUR
Stuttgart:M8W · This pageStuttgartGermanyEUR

Cash and shares

Aug 2026 deck · MediWound — Investor Presentation (August 2026)

Fully diluted
16.8 million

The slide these figures come from

Valuation

EV/sales 15.6× against a median of 9.0×: 6th lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$155.9M USD
P/E
Loss
EV/sales
15.6×
EV/EBITDA
Negative EBITDA
Price/book
5.5×
Gross margin
19.5%
Operating margin
−337.8%
Net margin
−235.0%
Debt to equity
0.3×
Beta vs S&P 500
0.64

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
MediWound Ltd. · NASDAQ:MDWDUS$175.5MUS$155.9Mn/a15.6×n/a5.5×−235.0%0.3×0.64
Antengene Corporation Limited · HKEX:6996US$183.1MUS$107.0Mn/a6.8×n/a1.3×−227.0%0.3×n/a
Whitehawk Therapeutics, Inc. · NASDAQ:WHWKUS$181.2MUS$11.70Mn/an/an/a1.1×n/a0.0×1.35
Sol-Gel Technologies Ltd. · NASDAQ:SLGLUS$180.6MUS$137.0Mn/a95.4×n/a4.2×n/a0.0×0.67
Tanvex BioPharma, Inc. · TWSE:6541US$180.5MUS$225.7Mn/a11.3×n/a1.2×−222.8%0.4×n/a
Korro Bio, Inc. · NASDAQ:KRROUS$179.4MUS$74.36Mn/a57.6×n/a2.0×n/a0.0×1.46
Vogenx Inc · NASDAQ:VOGXUS$176.3MUS$94.21Mn/an/an/a2.1×n/a0.0×n/a
Nanexa AB · OMXSTO:NANEXAUS$175.1MUS$170.1Mn/a51.4×n/a13.5×−72.5%0.0×n/a
Compugen Ltd. · NASDAQ:CGENUS$174.3MUS$59.55M4.8×0.8×n/a2.1×47.9%0.0×1.49
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H · HKEX:2591US$170.8MUS$39.93Mn/a2.1×n/a1.2×−259.6%0.2×n/a
Entrada Therapeutics, Inc. · NASDAQ:TRDAUS$170.3MUS$24.60Mn/a6.2×n/a0.9×n/a0.2×1.43
Median of the othersUS$177.8MUS$84.29M4.8×9.0×1.7×−222.8%0.0×1.43

Forecasts

5 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
29.67 USD · Analysts' mean
EPS, year to Dec 2026
-1.90 · 2 analysts
Revenue, year to Dec 2026
22.55M · 4 analysts

Team and board

Officers

OfficerRole
Ofer GonenChief Executive Officer
Hani LuxenburgChief Financial Officer
Shmulik HessChief Operating & Commercial Officer
Yaron MeyerEVP, General Counsel & Corporate Secretary
Alexandra TeplitskyVP Quality Assurance
Aya Ben YaakovVP Clinical & Regulatory Affairs
Barry J. WolfensonEVP Strategy & Corporate Development
Liron GalVP Manufacturing Science & Technology
Robert J. SnyderSVP, Global Medical Affairs
Ety KlingerChief Medical Officer

Board

DirectorRole
Nachum ShamirChairman
David FoxBoard Member
Shmuel RubinsteinBoard Member
Stephen T. WillsBoard Member
Vickie R. DriverBoard Member
Yaron MeyerEVP, General Counsel & Corporate Secretary

Events

Calls

CallWhenStatus
MediWound (NASDAQ:MDWD) Q3 2026 Earnings CallThu, Nov 12, 2026 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q2 2026 Earnings CallThu, Aug 13, 2026 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q1 2026 Earnings CallWed, May 27, 2026 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q4 2025 Earnings CallThu, Mar 05, 2026 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q3 2025 Earnings CallThu, Nov 20, 2025 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q2 2025 Earnings CallThu, Aug 14, 2025 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q1 2025 Earnings CallWed, May 21, 2025 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q4 2024 Earnings CallWed, Mar 19, 2025 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q3 2024 Earnings CallTue, Nov 26, 2024 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q2 2024 Earnings CallWed, Aug 14, 2024 · 8:30 AM ETReplay
All 25 calls
CallWhenStatus
MediWound (NASDAQ:MDWD) Q1 2024 Earnings CallWed, May 29, 2024 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q4 2023 Earnings CallThu, Mar 21, 2024 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q3 2023 Earnings CallTue, Nov 21, 2023 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q2 2023 Earnings CallWed, Aug 16, 2023 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q1 2023 Earnings CallTue, May 30, 2023 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q4 2022 Earnings CallThu, Mar 16, 2023 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q3 2022 Earnings CallTue, Nov 15, 2022 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q2 2022 Earnings CallTue, Aug 09, 2022 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q1 2022 Earnings CallTue, May 17, 2022 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q4 2021 Earnings CallThu, Mar 17, 2022 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q3 2021 Earnings CallTue, Nov 16, 2021 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q2 2021 Earnings CallTue, Aug 10, 2021 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q1 2021 Earnings CallWed, May 05, 2021 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q4 2020 Earnings CallThu, Feb 25, 2021 · 8:30 AM ETReplay
MediWound (NASDAQ:MDWD) Q3 2020 Earnings CallTue, Nov 10, 2020 · 8:30 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 12, 2026 · Before open−6.2%
Q2 2026Aug 13, 2026 · Before open−2.7%
Q1 2026May 27, 2026 · Before open−14.1%
Q4 2025Mar 5, 2026 · Before open−0.8%
Q3 2025Nov 20, 2025 · Before open−5.6%
Q2 2025Aug 14, 2025 · Before open−1.0%
Q1 2025May 21, 2025 · Before open−4.7%
Q4 2024Mar 19, 2025 · Before open−5.1%
Q3 2024Nov 26, 2024 · Before open−2.5%
Q2 2024Aug 14, 2024 · Before open−4.1%
All 20 quarters
QuarterResultsShare move
Q1 2024May 29, 2024 · Before open−10.0%
Q4 2023Mar 21, 2024 · Before open+2.1%
Q3 2023Nov 21, 2023 · Before open−1.9%
Q2 2023Aug 15, 2023 · After close−1.5%
Q1 2023May 30, 2023 · Before open−7.5%
Q4 2022Mar 16, 2023 · Before open−4.6%
Q3 2022Nov 15, 2022 · Before open+15.2%
Q2 2022Aug 9, 2022 · Before open−1.7%
Q1 2022May 17, 2022 · Before open−6.3%
Q4 2021Mar 17, 2022 · Before open−0.5%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck31 slidesNovember 2026
Investor Presentation (August 2026)Investor deck31 slidesAugust 2026
Q1 2026 Earnings PresentationEarnings31 slidesMay 27, 2026
Q4 2025 Earnings PresentationEarnings29 slidesMar 5, 2026
Investor Presentation (January 2026)Investor deck29 slidesJanuary 2026
Investor Presentation (November 2025)Investor deck29 slidesNovember 2025
Investor Presentation (August 2025)Investor deck29 slidesAugust 2025
Investor Presentation (May 2025)Investor deck29 slidesMay 2025
Investor Presentation (March 2025)Investor deck30 slidesMarch 2025
Investor Presentation (January 2025)Investor deck29 slidesJanuary 2025
All 17 decks
DeckKindSlidesDate
Investor Presentation (August 2024)Investor deck28 slidesAug 14, 2024
Technical Presentation (February 2024)Technical12 slidesFeb 12, 2024
Investor Presentation (January 2024)Investor deck29 slidesJan 8, 2024
Investor Presentation (May 2023)Investor deck22 slidesMay 31, 2023
Investor Presentation (January 2023)Investor deck20 slidesJan 9, 2023
Investor Presentation (July 2022)Investor deck12 slidesJul 12, 2022
Investor Presentation (June 2015)Investor deck26 slidesJun 4, 2015

Open Decks

Financings

RaiseDate
Bought deal of ordinary shares
Closed: US$17.25M raised · US$12.5 a share · H.C. Wainwright & Co., LLC
Dealers: H.C. Wainwright & Co., LLC (lead)
Use of proceeds: Working capital and general corporate purposes
Nov 5, 2026
Registered direct offering of ordinary shares
Closed: US$30M raised · US$17.3 a share · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Buyers: a prominent U.S.-based mutual fund
Use of proceeds: To advance the company's development programs and commercialization initiatives
Nov 20, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$14.00 a share on Mar 19, 2014.

Price
US$14.00 a share
Shares offered
5,000,000 ordinary shares
Offering size
US$70 million
Underwriters' option
Up to 750,000 more shares
Listing
MDWD on the Nasdaq Global Market
Underwriters
Credit Suisse, Jefferies, BMO Capital Markets, Oppenheimer & Co. · In the order on the cover
Shares delivered
On or about Mar 25, 2014

Steps

StepWhen
Draft sent to the SEC in confidenceDec 23, 2013
Filed publiclyFeb 10, 2014
Amended 3 timesNewest Mar 14, 2014
Shares registered with an exchangeMar 12, 2014
Declared effective by the SECMar 19, 2014
Final prospectus, with the priceMar 21, 2014

Open IPO · From the cover of the final prospectus (424B4) filed Mar 21, 2014

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue17.0M20.2M18.7M26.5M23.8M21.8M31.8M3.40M2.50M1.56M
Cost of revenue13.7M17.6M15.1M13.3M15.0M14.2M11.8M2.09M1.58M2.16M
Gross profit3.25M2.63M3.58M13.2M8.77M7.54M19.9M1.31M918.0K-600.0K
Research and development14.3M8.88M7.47M10.2M10.3M7.70M4.97M4.07M5.46M7.07M
Selling, general and administrative8.45M8.20M6.77M6.92M6.35M5.46M5.24M3.80M3.78M4.08M
Operating income-25.3M-19.4M-15.3M-8.35M-11.2M-8.84M4.49M-3.96M-13.7M-20.2M
Depreciation and amortization1.86M1.48M1.30M1.27M1.24M1.09M1.15M577.0K567.0K589.0K
EBITDA-23.4M-17.9M-14.0M-7.07M-9.98M-7.75M5.64M-3.38M-13.1M-19.6M
Interest expense2.46M12.8M1.89M11.6M2.31M1.28M2.98M2.12M1.25M896.0K
Income before tax-23.7M-30.2M-6.53M-19.5M-13.5M-9.28M2.07M-5.67M-14.5M-18.9M
Income tax169.0K61.0K185.0K78.0K27.0K00-9.69M8.46M-1.27M
Net income-23.9M-30.2M-6.72M-19.6M-13.6M-9.20M4.96M-1.06M-22.1M-18.9M
Earnings per share, basic-2.10-3.03-0.75-3.93-3.48-2.380.18-0.04-0.82-0.86
Earnings per share, diluted-2.10-3.03-0.75-3.93-3.48-2.38

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents4.80M9.15M11.9M33.9M11.0M17.4M7.24M6.72M36.1M28.9M
Short-term investments48.3M34.0M29.7M004.02M22.0M16.9M01.16M
Receivables1.62M4.80M3.70M9.33M1.78M2.77M4.11M560.0K369.0K332.0K
Inventory4.09M2.69M2.85M1.96M1.20M1.38M1.61M1.68M1.89M844.0K
Current assets60.0M52.2M49.7M45.8M15.0M26.2M35.6M32.7M41.5M33.6M
Property, plant and equipment18.6M14.1M9.23M2.37M2.48M2.63M2.30M2.02M1.92M1.28M
Total assets86.3M73.5M66.5M50.0M19.7M31.1M40.6M35.3M44.1M35.8M
Accounts payable7.65M5.28M5.53M5.66M4.69M2.99M4.07M2.71M3.25M3.32M
Current liabilities25.7M26.5M18.1M12.1M10.7M8.27M10.4M4.90M5.43M5.38M
Long-term debt7.38M6.84M
Total debt8.15M6.93M6.35M846.0K1.39M1.74M7.49M
Total liabilities42.6M42.3M34.9M39.1M24.3M23.8M25.4M26.3M34.5M28.0M
Shareholders' equity43.6M31.2M31.6M10.9M-4.58M7.27M15.2M8.97M9.37M7.77M
Shares outstanding12.8M10.8M9.22M7.24M3.90M27.2M27.2M27.2M27.0M21.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-16.1M-13.6M-10.5M-11.9M-8.92M-6.89M8.29M-12.2M-16.5M-16.4M
Capital spending-5.50M-6.27M-6.46M-555.0K-489.0K-923.0K-792.0K-522.0K-1.04M-671.0K
Free cash flow-21.6M-19.9M-16.9M-12.4M-9.40M-7.82M7.50M-12.7M-17.5M-17.1M
Cash from investing-17.9M-8.40M-34.3M-481.0K3.55M17.4M-6.90M-17.0M437.0K1.82M
Cash from financing29.6M19.4M22.9M35.8M-1.05M-629.0K-1.01M46.0K23.0M907.0K
Share buybacks22.7M7.00K
Change in cash-4.36M-2.71M-22.0M22.8M-6.33M10.3M3.36M-29.4M8.77M-13.6M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2026Big-stake noticeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
6-K · Report of a foreign issuerNov 12, 2026Current reportSEC
6-K · Report of a foreign issuerNov 5, 2026Current reportSEC
424B5 · ProspectusNov 5, 2026Offer documentSEC
FWP · Free writing prospectusNov 3, 2026Offer documentSEC
424B5 · ProspectusNov 3, 2026Offer documentSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipAug 28, 2026Insider tradeSEC
144 · Notice of proposed saleAug 28, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 28, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerAug 13, 2026Current reportSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 2, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
6-K · Report of a foreign issuerMay 27, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerMay 6, 2026Current reportSEC
6-K · Report of a foreign issuerApr 2, 2026Current reportSEC
6-K · Report of a foreign issuerMar 30, 2026Current reportSEC
3 · Initial statement of ownershipMar 25, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMar 5, 2026Offer documentSEC
20-F · Annual reportMar 5, 2026Annual reportSEC
6-K · Report of a foreign issuerMar 5, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 19, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 11, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerJan 15, 2026Current reportSEC
6-K · Report of a foreign issuerJan 12, 2026Current reportSEC
144 · Notice of proposed saleDec 3, 2025Other filingsSEC
6-K · Report of a foreign issuerNov 20, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 12, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 3, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerSep 30, 2025Current reportSEC
424B5 · ProspectusSep 30, 2025Offer documentSEC
6-K · Report of a foreign issuerSep 29, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeSep 19, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerAug 19, 2025Current reportSEC
6-K · Report of a foreign issuerAug 14, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerMay 21, 2025Current reportSEC
6-K · Report of a foreign issuerMay 15, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 12, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerApr 7, 2025Current reportSEC
424B3 · ProspectusMar 28, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveMar 28, 2025Other filingsSEC
CORRESP · Letter to the SECMar 25, 2025Other filingsSEC
UPLOAD · Letter from the SECMar 24, 2025Other filingsSEC
F-3 · Registration statementMar 19, 2025Offer documentSEC
S-8 · Registration statement for employee plansMar 19, 2025Offer documentSEC
20-F · Annual reportMar 19, 2025Annual reportSEC
6-K · Report of a foreign issuerMar 19, 2025Current reportSEC
6-K · Report of a foreign issuerFeb 12, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 11, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerJan 8, 2025Current reportSEC
6-K · Report of a foreign issuerDec 19, 2024Current reportSEC
6-K · Report of a foreign issuerDec 16, 2024Current reportSEC
6-K · Report of a foreign issuerNov 26, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerNov 14, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedOct 23, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeOct 1, 2024Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveSep 10, 2024Other filingsSEC
424B3 · ProspectusSep 9, 2024Offer documentSEC
CORRESP · Letter to the SECSep 5, 2024Other filingsSEC
UPLOAD · Letter from the SECSep 5, 2024Other filingsSEC
F-3 · Registration statementAug 29, 2024Offer documentSEC
6-K · Report of a foreign issuerAug 15, 2024Current reportSEC
6-K · Report of a foreign issuerAug 14, 2024Current reportSEC
6-K · Report of a foreign issuerAug 14, 2024Current reportSEC
6-K · Report of a foreign issuerAug 5, 2024Current reportSEC
SC 13D · Big-stake noticeJul 19, 2024Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedJul 19, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerJul 16, 2024Current reportSEC
6-K · Report of a foreign issuerJul 15, 2024Current reportSEC
6-K · Report of a foreign issuerJul 15, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedJul 11, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerJul 9, 2024Current reportSEC
6-K · Report of a foreign issuerMay 29, 2024Current reportSEC
6-K · Report of a foreign issuerMay 29, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedApr 25, 2024Big-stake noticeSEC
20-F · Annual reportMar 21, 2024Annual reportSEC
6-K · Report of a foreign issuerMar 21, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 12, 2024Current reportSEC
6-K · Report of a foreign issuerJan 9, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedJan 8, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerJan 8, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedJan 8, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerDec 28, 2023Current reportSEC
6-K · Report of a foreign issuerDec 15, 2023Current reportSEC
6-K · Report of a foreign issuerNov 21, 2023Current reportSEC
6-K · Report of a foreign issuerNov 21, 2023Current reportSEC
6-K · Report of a foreign issuerNov 13, 2023Current reportSEC
6-K · Report of a foreign issuerSep 26, 2023Current reportSEC
6-K · Report of a foreign issuerSep 21, 2023Current reportSEC
SC 13D/A · Big-stake notice, amendedSep 1, 2023Big-stake noticeSEC
S-8 · Registration statement for employee plansAug 15, 2023Offer documentSEC
6-K · Report of a foreign issuerAug 15, 2023Current reportSEC
6-K · Report of a foreign issuerAug 15, 2023Current reportSEC
6-K · Report of a foreign issuerAug 2, 2023Current reportSEC
6-K · Report of a foreign issuerJul 17, 2023Current reportSEC
6-K · Report of a foreign issuerJul 10, 2023Current reportSEC
6-K · Report of a foreign issuerJul 3, 2023Current reportSEC
6-K · Report of a foreign issuerMay 31, 2023Current reportSEC
6-K · Report of a foreign issuerMay 31, 2023Current reportSEC
6-K · Report of a foreign issuerMay 30, 2023Current reportSEC
6-K · Report of a foreign issuerMay 9, 2023Current reportSEC
6-K · Report of a foreign issuerApr 20, 2023Current reportSEC
424B3 · ProspectusApr 6, 2023Offer documentSEC
EFFECT · Notice that a registration is effectiveApr 6, 2023Other filingsSEC
POS AM · Amendment to an effective registrationMar 31, 2023Offer documentSEC
6-K · Report of a foreign issuerMar 16, 2023Current reportSEC
POS EXMar 16, 2023Other filingsSEC
424B3 · ProspectusMar 16, 2023Offer documentSEC
20-F · Annual reportMar 16, 2023Annual reportSEC
424B3 · ProspectusMar 16, 2023Offer documentSEC
6-K · Report of a foreign issuerMar 16, 2023Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedFeb 13, 2023Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 13, 2023Current reportSEC
SC 13G · Big-stake noticeFeb 8, 2023Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 7, 2023Current reportSEC
424B5 · ProspectusFeb 3, 2023Offer documentSEC
424B3 · ProspectusJan 9, 2023Offer documentSEC
6-K · Report of a foreign issuerJan 9, 2023Current reportSEC
424B3 · ProspectusJan 6, 2023Offer documentSEC
6-K · Report of a foreign issuerDec 29, 2022Current reportSEC
6-K · Report of a foreign issuerDec 23, 2022Current reportSEC
SC 13G · Big-stake noticeDec 21, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerDec 20, 2022Current reportSEC
6-K · Report of a foreign issuerDec 19, 2022Current reportSEC
6-K · Report of a foreign issuerDec 5, 2022Current reportSEC
SC 13G · Big-stake noticeDec 5, 2022Big-stake noticeSEC
SC 13G · Big-stake noticeDec 5, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerNov 28, 2022Current reportSEC
EFFECT · Notice that a registration is effectiveNov 28, 2022Other filingsSEC
424B3 · ProspectusNov 25, 2022Offer documentSEC
CORRESP · Letter to the SECNov 22, 2022Other filingsSEC
UPLOAD · Letter from the SECNov 16, 2022Other filingsSEC
6-K · Report of a foreign issuerNov 15, 2022Current reportSEC
6-K/A · Report of a foreign issuer, amendedNov 14, 2022Current reportSEC
F-1 · Registration statementNov 10, 2022Offer documentSEC
6-K · Report of a foreign issuerNov 9, 2022Current reportSEC
6-K · Report of a foreign issuerOct 21, 2022Current reportSEC
DOct 6, 2022Other filingsSEC
DOct 4, 2022Other filingsSEC
6-K · Report of a foreign issuerSep 26, 2022Current reportSEC
SC 13D/A · Big-stake notice, amendedSep 26, 2022Big-stake noticeSEC
424B5 · ProspectusSep 22, 2022Offer documentSEC
6-K · Report of a foreign issuerSep 20, 2022Current reportSEC
S-8 · Registration statement for employee plansAug 9, 2022Offer documentSEC
6-K · Report of a foreign issuerAug 9, 2022Current reportSEC
6-K · Report of a foreign issuerAug 8, 2022Current reportSEC
6-K · Report of a foreign issuerAug 3, 2022Current reportSEC
6-K · Report of a foreign issuerJul 19, 2022Current reportSEC
6-K · Report of a foreign issuerJul 12, 2022Current reportSEC
6-K · Report of a foreign issuerJul 11, 2022Current reportSEC
6-K · Report of a foreign issuerJul 7, 2022Current reportSEC
SC 13D/A · Big-stake notice, amendedJul 1, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerJun 30, 2022Current reportSEC
6-K · Report of a foreign issuerJun 9, 2022Current reportSEC
EFFECT · Notice that a registration is effectiveJun 6, 2022Other filingsSEC
CORRESP · Letter to the SECJun 1, 2022Other filingsSEC
UPLOAD · Letter from the SECMay 31, 2022Other filingsSEC
F-3 · Registration statementMay 25, 2022Offer documentSEC
6-K · Report of a foreign issuerMay 17, 2022Current reportSEC
6-K · Report of a foreign issuerMay 17, 2022Current reportSEC
6-K · Report of a foreign issuerMay 12, 2022Current reportSEC
6-K · Report of a foreign issuerMar 22, 2022Current reportSEC
SC 13D · Big-stake noticeMar 17, 2022Big-stake noticeSEC
20-F · Annual reportMar 17, 2022Annual reportSEC
6-K · Report of a foreign issuerMar 17, 2022Current reportSEC
424B5 · ProspectusMar 3, 2022Offer documentSEC
6-K · Report of a foreign issuerMar 3, 2022Current reportSEC
424B3 · ProspectusMar 2, 2022Offer documentSEC
6-K · Report of a foreign issuerMar 2, 2022Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 10, 2022Current reportSEC
SC 13G · Big-stake noticeFeb 2, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerJan 24, 2022Current reportSEC
6-K · Report of a foreign issuerDec 20, 2021Current reportSEC
6-K · Report of a foreign issuerDec 6, 2021Current reportSEC
6-K · Report of a foreign issuerNov 16, 2021Current reportSEC

This page holds 200 of 402 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from MediWound Ltd.’s releases · as of Nov 5, 2026

Common shares
12,910,278
Fully diluted
12,910,278

Fully diluted

LineShares
Common shares12,910,278

Share count over time

CountShares
Nov 22, 202612,910,278

Open Cap table

Shareholders

Funds

HolderSharesValueAs of
T. Rowe Price New Horizons Fund, Inc.246KUS$3.62MJun 30, 2026
iShares Russell 2000 ETF241KUS$3.54MJun 30, 2026
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund157KUS$2.31MJun 30, 2026
ARK Israel Innovative Technology ETF147KUS$2.07MJul 31, 2026
Fidelity Small Cap Index Fund110KUS$1.56MJul 31, 2026
iShares Russell 2000 Growth ETF91,113US$1.34MJun 30, 2026
Vanguard Russell 2000 Index Fund50,344US$721KMay 31, 2026
T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund40,939US$602KJun 30, 2026
iShares Micro-Cap ETF34,168US$502KJun 30, 2026
Schwab Small-Cap Index Fund24,270US$343KJul 31, 2026
Show 50 holders
HolderSharesValueAs of
Master Small Cap Index Series21,075US$310KJun 30, 2026
T.Rowe Price Small Cap Growth Portfolio20,500US$301KJun 30, 2026
U.S. Small Cap Equity Fund19,343US$273KJul 31, 2026
iShares Russell 3000 ETF13,088US$192KJun 30, 2026
Transamerica T. Rowe Price Small Cap VP12,300US$181KJun 30, 2026
Nuveen Small Cap Blend Index Fund10,799US$152KJul 31, 2026
EQ/2000 Managed Volatility Portfolio9,255US$136KJun 30, 2026
Fidelity Small Cap Growth Index Fund9,041US$133KJun 30, 2026
Vanguard Russell 2000 Growth Index Fund8,462US$121KMay 31, 2026
Fidelity Nasdaq Composite Index Fund6,967US$99,837May 31, 2026
Small Cap Index Fund5,369US$78,924Jun 30, 2026
LVIP State Street Small-Cap Index Fund5,200US$76,440Jun 30, 2026
Global X Russell 2000 ETF4,895US$69,117Jul 31, 2026
Small Cap Index Fund4,505US$64,557May 31, 2026
Invesco NASDAQ Future Gen 200 ETF4,442US$63,654May 31, 2026
State Street Small/Mid Cap Equity Index Portfolio3,800US$55,860Jun 30, 2026
EQ/Small Company Index Portfolio3,250US$47,775Jun 30, 2026
EQ/AB Small Cap Growth Portfolio2,350US$34,545Jun 30, 2026
1290 VT Micro Cap Portfolio2,328US$34,222Jun 30, 2026
Small-Cap Index Portfolio2,297US$33,766Jun 30, 2026
NVIT Small Cap Index Fund1,902US$27,959Jun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund1,759US$25,857Jun 30, 2026
ATM Small Cap Managed Volatility Portfolio1,707US$25,093Jun 30, 2026
DWS Small Cap Index VIP1,337US$19,654Jun 30, 2026
T. Rowe Price Small-Cap Index Fund1,218US$17,905Jun 30, 2026
EQ/Morgan Stanley Small Cap Growth Portfolio1,176US$17,287Jun 30, 2026
iShares Russell Small/Mid-Cap Index Fund1,124US$15,871Jul 31, 2026
BlackRock Small Cap Index V.I. Fund981US$14,421Jun 30, 2026
SA Small Cap Index Portfolio964US$13,612Jul 31, 2026
SmallCap Growth Fund I837US$11,818Jul 31, 2026
CVT Russell 2000 Small Cap Index Portfolio785US$11,540Jun 30, 2026
Nationwide Small Cap Index Fund728US$10,279Jul 31, 2026
Fidelity Small Cap Value Index Fund714US$10,496Jun 30, 2026
Venerable Small Cap Index Fund639US$9,393Jun 30, 2026
PD Small-Cap Growth Index Portfolio629US$9,246Jun 30, 2026
Vanguard Russell 3000 Index Fund610US$8,741May 31, 2026
Vanguard Russell 2000 Value Index Fund471US$6,749May 31, 2026
ProShares Russell 2000 High Income ETF459US$6,577May 31, 2026
Morgan Stanley Pathway Small-Mid Cap Equity ETF414US$5,933May 31, 2026
Destinations Small-Mid Cap Equity Fund397US$5,689May 31, 2026

This page holds 50 of 67 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Rubinstein Samuel
Director
Sale525USD 12.72US$6,678Sep 1, 2026
Rubinstein Samuel
Director
Buy525USD 12.62US$6,626Sep 1, 2026
Hess Shmuel
Officer: COO & Chief Commercial Officer
Sale1,979USD 12.72US$25,173Aug 27, 2026
Hess Shmuel
Officer: COO & Chief Commercial Officer
Sale1,979USD 13.13US$25,984Aug 27, 2026
Hess Shmuel
Officer: COO & Chief Commercial Officer
Sale1,865USD 13.00US$24,245Aug 26, 2026
Shamir Nachum
Director
Buy175USD 13.98US$2,447Jun 3, 2026
Shamir Nachum
Director
Buy5,825USD 14.00US$81,550Jun 3, 2026
Fox David Morton
Director
Buy1,730USD 14.23US$24,618Jun 1, 2026
Fox David Morton
Director
Buy10USD 14.23US$142Jun 1, 2026
Fox David Morton
Director
Buy1,797USD 14.00US$25,158Jun 1, 2026
All 11 trades
TradeTradeSharesPriceValueDate
Rubinstein Samuel
Director
Buy150USD 14.33US$2,150May 29, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Nachum Shamir
Other companies: Stereotaxis, Inc. (Director · Since at least Jul 18, 2024); IsoPlexis Corp (Director · Aug 22, 2022 – Mar 21, 2023 · Past); Cactus Acquisition Corp. 1 Limited (Director · Oct 28, 2021 – Oct 28, 2021 · Past); STRATA Skin Sciences, Inc. (Director · May 30, 2018 – Jul 5, 2023 · Past); Cogentix Medical Inc (Director · Nov 3, 2016 – Apr 23, 2018 · Past)
Chairman · Since at least Mar 18, 2026
Stephen T. Wills
Other companies: Palatin Technologies, Inc. (Executive VP and CFO/COO · Since at least Dec 6, 2023); Viskase Holdings, Inc. (Director · Jan 7, 2025 – Jan 7, 2025 · Past); Gamida Cell Ltd (Director · Oct 19, 2023 – Jan 31, 2024 · Past)
Director · Since at least Mar 18, 2026
Ofer Gonen
Other companies: Gamida Cell Ltd (Director · Jan 1, 2022 – Jan 1, 2022 · Past); Cactus Acquisition Corp. 1 Limited (Chief Executive Officer, Director · Oct 28, 2021 – Oct 28, 2021 · Past)
Chief Executive Officer · Since at least Mar 18, 2026
David Fox
Other companies: Archer Aviation Inc. (Director · Oct 27, 2020 – Sep 16, 2021 · Past)
Board Member · Since at least Mar 18, 2026
Samuel Rubinstein
Other companies: STRATA Skin Sciences, Inc. (Director · Since at least May 30, 2018)
Director · Since at least Mar 18, 2026
Alexandra TeplitskyVP Quality Assurance · Since at least Nov 5, 2026
Aya Ben YaakovVP Clinical & Regulatory Affairs · Since at least Nov 5, 2026
Barry J. WolfensonEVP Strategy & Corporate Development · Since at least Nov 5, 2026
Ety KlingerChief Medical Officer · Since at least Mar 18, 2026
Hani LuxenburgChief Financial Officer · Since at least Nov 3, 2026
All 19 people
PersonSeat
Kalfon Hana LuxenburgChief Financial Officer · Since at least Mar 18, 2026
Liron GalVP Manufacturing Science & Technology · Since at least Nov 5, 2026
Robert J. SnyderSVP, Global Medical Affairs · Since at least Apr 28, 2025
Shmuel HessCOO & Chief Commercial Officer · Since at least Mar 18, 2026
Shmuel RubinsteinBoard Member · Since at least Nov 5, 2026
Shmulik HessChief Operating & Commercial Officer · Since at least Nov 3, 2025
Vickie R. DriverBoard Member · Since at least Mar 18, 2026
Yaakov Aya BenVP Clinical & Reg. Affairs · Since at least Mar 18, 2026
Yaron MeyerEVP, General Counsel & Corporate Secretary · Since at least Mar 18, 2026

Open People

Log in to ask 6ix AI your own questions about MediWound Ltd.